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(WM) degeneration that may be due to an early breakdown
in axon myelination but in vivo imaging correlates of
demyelination remain relatively unexplored in HD compared
to other neurodegenerative diseases. This study investi-
gated HD-related eﬀects on a putative marker of myelin,
the macromolecular proton fraction (MMPF) from quantita-
tive magnetization transfer and on fractional anisotropy,
axial and radial diﬀusivity from diﬀusion tensor MR-
imaging. Microstructural diﬀerences were studied in WM
pathways of the basal ganglia and motor systems known
to be impaired in HD: the corpus callosum, the cortico-
spinal tract, the anterior thalamic radiation, ﬁbers between
prefrontal cortex and caudate and between supplementary
motor area and putamen. Principal component analysis
was employed for dimensionality reduction. Patients
showed reductions in a component with high loadings on
MMPF in all WM pathways and a trend for increases in a
component loading on axial and radial diﬀusivities but no
diﬀerences in a component loading on fractional anisotropy.
While patients’ performance in executive functioning was
impaired, their working memory span was preserved. Inter-
individual diﬀerences in the diﬀusivity component corre-
lated with patients’ performance in clinical measures ofhttp://dx.doi.org/10.1016/j.neuroscience.2017.05.042
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1the United Huntington Disease Rating Scale. In summary,
HD-related reductions in MMPF suggest that myelin break-
down contributes to WM impairment in human HD and
emphasize the potential of quantitative MRI metrics to
inform about disease pathogenesis. Disease severity in
manifest HD, however, was best captured by non-speciﬁc
diﬀusivity metrics sensitive to multiple disease and age-
related changes.
This article is part of a Special Issue entitled: MRI and
Neuroinflammation.  2017 The Author(s). Published by
Elsevier Ltd on behalf of IBRO. This is an open access article
under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).
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INTRODUCTION
Huntington’s disease (HD) is a progressive
neurodegenerative disease caused by an expansion and
instability of the cytosine-adenine-guanine triplet repeat
(CAG repeat) in the Huntingtin gene. Individuals with
HD exhibit a progressive decline of motor and cognitive
functions, notably executive functions (Mo¨rkl et al.,
2016), as well as disturbances in aﬀect and motivation
(Papoutsi et al., 2014).
Mutation carriers not only show gray matter atrophy in
the basal ganglia (BG) but also subtle and progressive
white matter (WM) impairment many years before the
onset of any clinical symptoms (Dayalu and Albin,
2015). Microstructural impairments at prodromal disease
stages have been identiﬁed for major WM bundles includ-
ing the corpus callosum, the anterior thalamic radiation
and the cortico-spinal tract (Matsui et al., 2015; Novak
et al., 2014, 2015; Phillips et al., 2014, 2015; Odish
et al., 2015; Poudel et al., 2015; Steventon et al., 2015).
Alterations in WM microstructure are related to early stri-
atal atrophy (Novak et al., 2014), to disease progression
(Rosas et al., 2006; Gregory et al., 2015) and early cogni-
tive dysfunctions (Matsui et al., 2015).
The majority of studies into WM in HD (Rosas et al.,
2006; Gregory et al., 2015; Poudel et al., 2015) have
employed diﬀusion tensor magnetic resonance imaging
(DT-MRI) to characterize and quantify WM microstruc-
tural changes with metrics of fractional anisotropy (FA)
or diﬀusivities (Basser et al., 1994). DT-MRI indices are
sensitive to microstructural changes in many neurodegen-/licenses/by/4.0/).
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(Metzler-Baddeley et al., 2012a; Metzler-Baddeley et al.,
2012b), Alzheimer’s disease (Acosta-Cabronero and
Nestor, 2014), Parkinson’s Disease (Bohnen and Albin,
2011; Mole et al., 2016) and Multiple Sclerosis (Abhinav
et al., 2014). However, changes in DT-MRI metrics are
diﬃcult to interpret biologically since they lack any speciﬁc
pathological counterpart and can occur due to changes in
the ﬁber organization and orientation complexity as well
as in axon caliber and myelination (Beaulieu and Allen,
1994; De Santis et al., 2014). By using a multi-modal
approach that complements DT-MRI metrics with other
modalities sensitive to WM tissue properties one may
therefore gain more speciﬁc clues about the potential
underlying mechanisms aﬀecting WM microstructure in
HD.
Bartzokis et al. (2007) utilized MRI at two diﬀerent ﬁeld
strengths (0.5 T and 1.5 T) to quantify the iron content of
ferritin molecules in white and gray matter of eleven HD
patients compared to controls. In patients, decreased fer-
ritin iron levels were found in the genu of the corpus cal-
losum and the frontal WM accompanied by increased
levels in the BG while no diﬀerences between the groups
were present in the hippocampus and the thalamus as
control regions. More recently, Phillips et al. (2015) using
T2
* -weighted imaging also reported elevated iron levels in
the cortico-spinal tract of HD patients. As iron is required
for the formation of myelin, which in turn is essential for
the development and maintenance of healthy brain func-
tion, these ﬁndings suggest myelin disturbance (Fields,
2014). Myelin insulates and protects axons and enables
saltatory conduction, i.e., the process of action potentials
moving in discrete jumps along a myelinated axon to
speed up information transfer between neurons. In the
central nervous system myelin is produced and repaired
by oligodendrocyte glia cells, which are the cells with
the highest iron concentration in the human brain
(Koeppen, 1995).
The view that myelin disturbance may play a critical
role in HD is backed up by recent evidence from post-
mortem and animal studies. Using a variety of
techniques, including carbon dating, one post-mortem
study of brain tissue from individuals with HD has
suggested decreased proliferation of striatal
oligodendrocyte lineage cells (Ernst et al., 2014). Further-
more, Teo et al. (2016) reported thinner myelin sheaths in
ﬁbers of the corpus callosum in HD knock-in mice at an
early age before any striatal neuronal loss could be
detected. Similarly, reduced levels of myelin regulatory
factor and myelin basic protein and decreased numbers
of myelinated axons in the corpus callosum were reported
in other HD mice model studies (Huang et al., 2015; Jin
et al., 2015). Together these results suggest that an early
breakdown of myelination followed by homeostatic
responses of increased levels of oligodendrocytes and
iron may contribute to the pathogenesis of HD
(Bartzokis et al., 2007). However, in vivo correlates of
demyelination in human HD remain relatively unexplored
compared to other neurodegenerative diseases such as
multiple sclerosis, despite their potential in helping to bet-Please cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgter understand the pathogenesis of the disease and in
providing biomarkers for the eﬃcacy of therapeutics.
The present study investigated HD-related diﬀerences
in WM microstructure by utilizing both high angular
resolution diﬀusion imaging (HARDI) (Tuch et al., 2002)
and quantitative magnetization transfer imaging (qMT)
(Henkelman et al., 1993, 2001) which provides improved
myelin speciﬁcity compared to diﬀusion MRI. qMT esti-
mates the liquid and semisolid constituents of tissue by
applying an oﬀ-resonance radiofrequency pulse with
time-varying amplitude to selectively saturate the macro-
molecular magnetization. This results in a reduction of
the measured signal due to the magnetization transfer
between saturated macromolecules and free water
(Sled and Pike, 2000; Ramani et al., 2002). Molecules
associated with myelin have been shown to dominate
the magnetization transfer exchange process in WM
(Koenig, 1991; Odrobina et al., 2005) and the relative
density of the macromolecular pool, the macromolecular
proton fraction (MMPF), has been found to be speciﬁc
to myelin content of the optic nerve in shiverer versus
control mice (Ou et al., 2009), to be sensitive to demyeli-
nation processes in multiple sclerosis (Levesque et al.,
2010; Liu et al., 2015) and to depend on the myelin con-
tent of WM in post-mortem histology studies of human
multiple sclerosis brains (Schmierer et al., 2007). Thus,
although magnetization transfer will also be inﬂuenced
by other processes such as inﬂammation and T1 changes,
MMPF has been proposed as a proxy MRI marker of mye-
lin (Serres et al., 2009b,a).
The aim of the present study was to investigate
whether MMPF as a marker of myelin would be a
sensitive MRI metric for WM microstructural alterations
in HD. For the purpose of comparability with previous
research (Gregory et al., 2015; Poudel et al., 2015) we
also studied HD-related changes in FA, radial diﬀusivity
(RD) and axial diﬀusivity (AD) from DT-MRI, appreciating
however that there are inherent problems of interpreting
diﬀerences in these metrics in terms of myelin breakdown
or axonal degeneration (Wheeler-Kingshott and
Cercignani, 2009).
WM microstructure was studied in pathways of the BG
and motor systems which are known to be aﬀected in HD,
i.e., the anterior thalamic radiation (Matsui et al., 2015),
the cortico-spinal tract (Phillips et al., 2015) and distinct
sections of the corpus callosum (Hofer and Frahm,
2006) (Fig. 1). In addition, we reconstructed connections
that form part of the BG loops, i.e., pathways between
the prefrontal cortex (PFC) and the caudate nucleus
(PFC-caudate) and between the supplementary motor
area (SMA) and the putamen (SMA-putamen)
(Alexander and Crutcher, 1990; Postuma and Dagher,
2006) (Fig. 1). Average indices of MMPF, FA, AD and
RD were obtained for each of these tracts.
Following previous evidence suggesting impaired
myelination as a signiﬁcant contributor to WM
abnormalities in HD (Bartzokis et al., 2007; Ernst et al.,
2014; Teo et al., 2016) our primary hypothesis predicted
lower MMPF in the WM pathways of patients compared
to controls. Based on previous evidence (e.g. Gregoryhuman Huntington’s disease: Multi-modal evidence from diffusion MRI
/10.1016/j.neuroscience.2017.05.042
Fig. 1. White matter pathway regions of interest. Sagittal and axial views of the reconstructed white matter pathways displayed on a T1-weighted
image for one control participant. (A) segments I, II, and III of the corpus callosum (Hofer and Frahm, 2006), (B) anterior thalamic radiation, (C)
prefrontal cortex – caudate pathway, (D) cortico-spinal tract and (E) supplementary motor area – putamen pathway. Fiber directions are color-coded
with green indicating directions along the coronal, blue along the axial and red along the sagittal plane (Pajevic and Pierpaoli, 1999). (F) displays all
reconstructed pathways on a sagittal view of the left hemisphere for another control participant. The corpus callosum segments are displayed in red
(segment I) and orange (segments II and III), the anterior thalamic radiation in yellow, the prefrontal cortex – caudate ﬁbers in blue, the
supplementary motor area – putamen ﬁbers in dark blue and the cortico-spinal tract in green.
J. Bourbon-Teles et al. / Neuroscience xxx (2017) xxx–xxx 3et al., 2015) we also expected reduced FA and higher RD
and AD in patients relative to controls.
As secondary research questions we investigated the
potential relationships between variation in WM
microstructure and variation in gray matter volume of
the bilateral BG (caudate, the putamen, the globus
pallidus) and the thalamus. We also explored
correlations between inter-individual variations in WM
microstructure and cognitive functions as well as clinical
markers from the United Huntington’s Disease Rating
Scale (UHDRS) (Siesling et al., 1998) to assess brain-
function relationships.EXPERIMENTAL PROCEDURES
Participants
This study obtained National Health Service (NHS)
Research Ethics Committee approval (13/WA/0326) and
all participants gave written informed consent in
accordance with the Declaration of Helsinki. Twenty-four
patients with manifest HD and one pre-symptomaticPlease cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgindividual (total n= 25) were recruited from the South
Wales HD clinic based in Cardiﬀ and the Bristol HD
clinic. A group of age- and sex-matched healthy controls
(n= 13) were recruited from the Cardiﬀ University
School of Psychology community panel and from
patients’ spouses, carers or family members. Table 1
summarizes the patients’ demographic and some
background clinical characteristics i.e., their CAG repeat
length, their UHDRS-Total Motor Score (TMS) and
UHDRS-Functional Assessment Score (FAS) and
information about their medication.
All patients had a conﬁrmed genetic diagnosis of
Huntington’s disease (Table 1). One patient was pre-
symptomatic and all other patients were symptomatic at
various stages of the disease ranging from early through
to moderately advanced stages. Patients had to be on a
stable medication regime for at least four weeks prior to
taking part in the study. Individuals were excluded from
participation in the study if they had any other
neurological conditions or a history of severe head
injury, stroke or cerebral hemorrhages. To undergohuman Huntington’s disease: Multi-modal evidence from diffusion MRI
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Table 1. Patients’ demographics and background clinical information
Patients Age Sex Length of
CAG repeats
TMS FAS Medication
HD01 42 F 45 41 21 Olanzepine 5 mg, Citalopram 20 mg, Pregabalin 50 mg, Depakote 250 mg
HD02 46 F 40 9 24 Nil
HD03 24 M 43 2 25 Nil
HD04 38 F 45 10 22 Amitriptyline 75 mg, Omeprazole 10 mg, Prochlorperazine 10 mg,
HD05 60 M 43 48 17 Olanzepine 12 mg
HD06 45 F 42 46 16 Natriliz 1.5 mg, Rosuvasatin 10 mg, Atenolol 25 mg Carioplan 5 mg, Quetiapine
700 mg Metformin 500 mg, Indomethocin 25 mg, Pendopril 4 mg
HD07 55 M 43 82 13 Olanzapine 20 mg, Propanolol 30 mg, Cetrizine, Fortisips, Temazepam 10 mg
HD08 49 M 42 7 23 Nil
HD09 64 M 41 19 23 Citalopram 40 mg
HD10 44 F 47 72 1 Trazodone 300 mg, Abilify 5 mg, Temazepam 10 mg, Pregabalin 150 mg.
HD11 44 F 46 35 24 Citalopram 40 mg, Zopiclone 37.5 mg, Co-codamol 2 tables
HD12 64 M 40 35 22 Aspirin 75 mg, Atorvastatin 40 mg, Perindopril 4 mg, Sumatriptan 50 mg
HD13 46 M 45 35 13 Gabapentin 600 mg, Citalopram 30 mg,
HD14 22 M 51 17 23 Citalopram 30 mg
HD15 28 F 51 61 18 Perampanel 8 mg, Lamotrigine 100 mg, Levetiracetam 1500 mg, Clobazam up to
10 mg
HD16 47 M 46 69 18 Sertraline 50 mg,
HD17 62 F 41 4. 25 Novate ointments, Naproxen
HD18 50 M 40 0 25 Nil
HD19 68 F 43 40 17 Mirtazapine 30 mg
HD20 58 M 43 0 25 Atorvastatin 20 mg
HD21 58 M 41 37 25 Amlodipine 5 mg, Bendroﬂumethiazide 2.5 mg, Metformin 500 mg, Ramipril 2.5 mg,
Sertraline 100 mg
HD22 30 F 42 0 25 Nil
HD23 37 F 46 6 25 Co-codamol 30/500, Omeprazole 10 mg, Ventolin inhaler 2 puﬀs, Amitriptyline 50 mg
HD24 51 M 43 20 23 Co-codamol 500 mg, Brufen 400 mg
HD25 47 F 41 5 25 Kliofem 2 mg, Amitriptyline 150 mg, Omeprazole 20 mg, Rizatriptan 10 mg, Loratidine
10 mg
Mean 47.2 – 44 28 20.7
SD 12.5 3.1 24.9 5.65
Abbreviations: CAG= cytosine-adenine-guanine, F = Female, M=Male, TMS= Total Motor Score out of 124 (the higher the scores the more impaired the performance).
FAS = Functional Assessment Score out of 25 (the higher the scores the better the performance). HD= Huntington’s disease, SD= Standard Deviation.
4 J. Bourbon-Teles et al. / Neuroscience xxx (2017) xxx–xxxbrain imaging, participants also had to be eligible for MRI
scanning i.e., without contraindications such as
pacemakers, metal clips, stents, claustrophobia or
signiﬁcant chorea which would have prevented them
from lying still in the scanner.Cognitive Assessment
Diﬀerent aspects of working memory and executive
functions, i.e., multi-tasking, working memory span,
attention switching, distractor suppression and
processing speed capacities were tested with the
following standard paper and pencil neuropsychological
tests: (1) The ability to multi-task was assessed with a
dual task requiring the simultaneous crossing out of
boxes on a sheet of paper and repeating sequences of
digits at an individual’s short-term memory span
(Baddeley, 1996). Participants’ performance was also
assessed in each task individually. (2) The ability to switch
attention was assessed with a verbal version of the trails
test (VT), which requires the generation of letter and digit
sequences in alternate order (Baddeley, 1996). Switching
costs were assessed relative to generating letter or digit
sequences alone. (3) The ability to suppress distracting
and response incongruent information was measured with
the Stroop task, which requires the reading of color wordsPlease cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgat baseline and ﬁltering out incongruent ink color as inter-
ference condition (Trenerry et al., 1989). (4) Visuo-motor
working memory capacities and processing speed were
assessed with the Digit Symbol Substitution Test (DSST)
from the Wechsler Adult Intelligence Scale (Wechsler,
1999). (5) Verbal and category ﬂuencies were assessed
using the letter cues ‘‘F”, ‘‘A”, ‘‘S” and ‘‘M”, ‘‘C”, ‘‘R” as well
as the categories of ‘‘animals” and ‘‘boys’ names” and
‘‘supermarket items” and ‘‘girls’ names” respectively
(Delis et al., 2001).
Previous pilot research identiﬁed correctly generated
responses and response times in these tests as the
most sensitive performance estimates (compared to
error scores) in patients with HD (Metzler-Baddeley
et al., 2014). Therefore the present study adopted these
performance scores, leading to a total of 14 cognitive
measurements, which are summarized in Table 5.MRI data acquisition
MRI data were acquired on a 3 T General Electric HDx
MRI system (GE Medical Systems, Milwaukee) using an
eight channel receiver only head RF coil at the Cardiﬀ
University Brain Research Imaging Centre (CUBRIC).
The MRI protocol was comprised of T1-weighted,
diﬀusion-weighted and quantitative magnetizationhuman Huntington’s disease: Multi-modal evidence from diffusion MRI
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spoiled gradient recalled (FSPGR) scan was acquired
with the following parameters: 256  256 acquisition
matrix, TR = 7.8 ms, TE = 2.9 ms, ﬂip angle = 20, 172
slices, 1-mm slice thickness, FOV= 23 cm. Diﬀusion
data were acquired employing a spin-echo echo-planar
High Angular Resolution Diﬀusion Imaging (HARDI)
(Tuch et al., 2002) sequence with diﬀusion encoded along
60 isotropically distributed orientations and six non-
diﬀusion weighted scans according to an optimized gradi-
ent vector scheme (Jones et al., 1999) (96  96 acquisi-
tion matrix, TR/TE = 87 ms, b-value = 1200 s/mm2, 60
slices, 2.4-mm slice thickness, spatial resolution
1.8  1.8  2.4 mm). Diﬀusion data acquisition was
peripherally gated to the cardiac cycle with a total acquisi-
tion time of 30 min depending on the heart rate.
An optimized 3D MT-weighted fast spoiled gradient
recalled-echo (SPGR) sequence (Cercignani and
Alexander, 2006) was used to obtain magnetization
transfer-weighted data with the following parameters:
TR/TE = 25.82/2.18 ms; Gaussian MT pulses, duration
t = 14.6 ms; acquisition matrix = 96x96x60; BW=
± 244 Hz; FOV= 24 cm. The following oﬀ-resonance
irradiation frequencies (H) and their corresponding satu-
ration pulse amplitude (DSAT) for the 11 MT-weighted
images were optimized using Cramer-Rao lower bound
optimization [56]: H= [1000 Hz, 1000 Hz, 12,062 Hz,
47,185 Hz, 56,363 Hz, 2751 Hz, 1000 Hz, 1000 Hz,
2768 Hz, 2791 Hz, 2887 Hz] and their corresponding
DSAT= [332, 333, 628, 628, 332, 628, 628,
628, 628, 628, 628]. The longitudinal relaxation rate
of the system was estimated by acquiring T1-maps using
3D SPGRs (TR= 6.85 ms, TE = 1.2 ms, FOV and reso-
lution is the same as the MT sequence) with three diﬀer-
ent ﬂip angles (theta = 15,7,3). Data for computing ﬁeld
(B0) maps were collected using two 3D spoiled, gradient
recalled acquisitions (SPGR) with diﬀerent echo-times
(TE = 9 ms and 7 ms respectively; TR = 20 ms;
matrix = 128  128; FOV= 220 mm; slice thickness
3 mm) (Jezzard and Balaban, 1995).
MRI data processing
The diﬀusion-weighted HARDI data were corrected for
distortions induced by the diﬀusion-weighted gradients,
artifacts due to head motion and due to EPI-induced
geometrical distortions by registering each image
volume to the high-resolution T1–weighted anatomical
images (Irfanoglu et al., 2012) with appropriate reorienta-
tion of the encoding vectors (Leemans and Jones, 2009)
in ExploreDTI (Version 4.8.3) (Leemans et al., 2009).
Since HD is associated with signiﬁcant atrophy of brain
tissue, DT-MRI metrics were corrected for cerebrospinal
ﬂuid based partial volume artifacts with the two compart-
ment Free Water Elimination (FWE) approach
(Pasternak et al., 2009) to derive maps of free water cor-
rected FA, AD and RD (Pierpaoli and Basser, 1996).
MT-weighted SPGR volumes for each participant
were co-registered to the MT-volume with the most
contrast using an aﬃne (12 degrees of freedom, mutual
information) registration to correct for inter-scan motion
using Elastix (normalized mutual information costPlease cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgfunction) (Klein et al., 2010). The 11 MT-weighted SPGR
images and T1-maps were modeled by the two pool
Ramani’s pulsed MT approximation (Ramani et al.,
2002). This approximation provided maps of the macro-
molecular proton fraction MMPF, which were nonlinearly
warped to the T1-weighted SGPR image using the MT-
volume with the most contrast as a reference using
Elastix.Tractography
Whole brain tractography was performed for each
participant in their native space using the damped
Richardson-Lucy algorithm (dRL) (Dell’acqua et al.,
2010), which (in contrast to diﬀusion tensor based tractog-
raphy) allows the recovery of multiple ﬁber orientations
within each voxels including those aﬀected by partial vol-
ume. To reconstruct ﬁber tracts, dRL ﬁber orientation den-
sity functions (fODFs) were estimated at the center of
each image voxel. Seed points were positioned at the ver-
tices of a 2  2  2-mm grid superimposed over the
image. The dRL tracking algorithm interpolated local
fODF estimates at each seed point and then propagated
0.5 mm along orientations of each fODF lobe above a
threshold peak of 0.05. This procedure allowed four
potential streamlines to emanate from each seed point.
Individual streamlines were subsequently propagated by
interpolating the fODF at their new location and propagat-
ing 0.5 mm along the minimally subtending fODF peak.
This process was repeated until the minimally subtending
peak magnitude fell below 0.05 or the change of direction
between successive 0.5-mm steps exceeded an angle of
45. Tracking was then repeated in the opposite direction
from the initial seed point. Streamlines whose lengths
were outside a range of 10 mm to 500 mm were
discarded.
Three dimensional ﬁber reconstructions of the WM
tracts of interest were made by applying waypoint region
of interest (ROI) gates (‘‘AND”, ‘‘OR” and ‘‘NOT” gates
following Boolean logic) to isolate speciﬁc tracts from
the whole brain tractography data. ROIs were drawn
manually by one operator (JBT) blind to the identity of
each dataset on color-coded ﬁber orientation maps in
native space guided by anatomical landmark protocols.
Three distinct sections of the corpus callosum (CC)
were reconstructed following the protocol by Hofer and
Frahm (2006). These were sections maintaining ﬁbers
between the prefrontal cortices (CC1), the premotor and
SMA cortices (CC2) and the motor cortices (CC3)
(Fig. 1A). The reconstructions of the anterior thalamic
radiation (ATR) (Fig. 1B) and the corticospinal tract
(CST) (Fig. 1D) were based on the anatomical ﬁber atlas
by Wakana et al. (2004). The segmentation of ﬁbers
between the PFC and the caudate (Fig. 1C) were guided
by Kamali et al. (2010) and those between SMA and puta-
men (Fig. 1E) by Leh et al. (2007).Extraction of subcortical BG and thalamic volume
from T1-weighted anatomical images
Gray-matter subcortical volumes for left and right
caudate, putamen, pallidum and thalamus werehuman Huntington’s disease: Multi-modal evidence from diffusion MRI
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the FMRIB Software Library (FSL) FIRST registration
and segmentation tool (Patenaude et al., 2011) (www.
fsl.fmrib.ox.ac.uk/fsl/fslwiki/FIRST). The FIRST proce-
dure involves as a ﬁrst step the registration of each indi-
vidual’s T1-weighted image to the Montreal Neurological
Institute (MNI) standard template with aﬃne registration.
During this step voxels outside subcortical regions are
excluded using an MNI subcortical mask. FIRST then
applies a Bayesian model of shape recognition to perform
segmentation of subcortical structures. The segmented
images were uploaded onto the original T1-weighted
images and were visually inspected for correct registra-
tion for all participants. Quantitative volume measures
from the BG and thalamus segmentations were extracted
using the FSL statistics tool.
In addition all FIRST subcortical volumes were
corrected for head size with the volumetric scaling factor
derived from SIENAX version 2.5 (part of FSL4.1, http://
www.fmrib.ox.ac.uk/fsl) (Smith et al., 2001). This involved
skull extraction with BET and an aﬃne-registration to the
Montreal Neurological Institute (MNI) standard template.
The volumetric scaling factor/value was extracted and
used as the normalization factor to obtain for head size
corrected volumes (i.e. by multiplying the volumetric scal-
ing value with the subcortical volumes obtained from
FIRST).
Statistical analysis
All statistical analyses were carried out using SPSS
Version 20 (IBM, 2011). All data were inspected for out-
liers deﬁned as values larger or smaller than three times
the standard deviation from the mean.
Since microstructural MRI metrics have been
previously reported to be highly correlated between WM
pathways (Penke et al., 2010, 2012) it is important to rec-
ognize that the 44 WM metrics [4 indices (MMPF, FA, AD,
RD) x 11 tracts (CC1, CC2, CC3 and CST, ATR, PFC-
caudate, SMA-putamen on both hemispheres)] may not
be independent but could be impure measures of overlap-
ping latent constructs. To account for this possibility we
employed an exploratory principal component analysis
(PCA) to identify the minimum number of uncorrelated
principal components that explained together the maxi-
mum amount of variance in the microstructural data
(Joliﬀe, 1986). PCA was also employed to reduce the
dimensionality of the eight gray matter volume data (cau-
date, putamen, pallidum and thalamus on both hemi-
spheres) and the 14 cognitive outcome measures
(Table 5).
Due to the relatively small sample size for PCA
(n= 32 for WM microstructural and gray matter volume
data and n= 33 for cognitive data) we followed
recommendations to limit the number of extracted
components to a minimum (Preacher and MacCallum,
2002; de Winter et al., 2009). Selecting the number of
components for data summary is always a trade-oﬀ
between choosing too few components that may miss
important underlying structures and too many compo-
nents that reﬂect noise. Since there is no single recom-
mended method we adopted the following approach:Please cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgFirstly, we employed the SPSS default of the Kaiser crite-
rion of including all components with an eigenvalue >1,
secondly we inspected Cattell’s scree plots (Cattell,
1952) to identify the minimal number of components that
accounted for most of the data variability and thirdly we
assessed the selected components with regard to their
interpretability. We used a PCA procedure with orthogo-
nal Varimax rotation of the factor matrix, whereby each
component has a small number of large loadings and a
large number of small loadings. Tables 3–5 summarize
the component loadings for the WM microstructural, gray
matter volumetric and cognitive data respectively. Per
convention, loadings that exceeded a value of 0.5 were
considered as signiﬁcant.
We then tested for group diﬀerences in the principal
component scores with independent t-tests and
assessed the eﬀect sizes with Cohen’s d (Cohen, 1988).
Group diﬀerences in component scores were interpreted
by referring to the variables with signiﬁcant component
loadings as highlighted in bold in Tables 3–5.
Spearman’s rho correlation coeﬃcients were
calculated between WM microstructural component
scores, gray matter volumetric component scores,
cognitive component scores and the clinical measures
from the UHDRS to assess disease-related brain-
function relationships. Signiﬁcant correlations were
further assessed with partial correlations to control for
potentially mediating variables of age, number of CAG
repeats and years of education (YoE).
All statistical tests were corrected for multiple
comparison errors with the Bonferroni correction with a
family-wise alpha level of 5% (two-tailed) leading to a
corrected p-value of <0.0167 for three independent t-
tests for WM microstructure, p< 0.025 for two
independent t-tests for cognition, p< 0.049 for one gray
matter volumetric component and p< 0.003 for sixteen
Spearman correlation coeﬃcients.RESULTS
Four individuals (HD11, HD12, HD21 and one control)
turned out not eligible for MRI scanning due to
claustrophobia and metal contamination and only
performed the behavioral part of the study. One
patient’s MRI data had to be discarded due to excessive
motion (HD07). One control individual was excluded due
to an incidental MRI ﬁnding. Thus, the analysis of the
MRI data was based on 21 patients and 11 controls.
Please also note that four patients at more advanced
stages (HD07, HD10, HD12, HD13) could not perform
all cognitive tasks. One patient’s (HD10) diﬀusivity data
and one control participant’s BG volume data were
identiﬁed as outliers. Results will be reported before and
after outlier exclusion.
Table 2 summarizes information about demographic
variables and performance in the Montreal Cognitive
Assessment (MoCA) (Nasreddine et al., 2005) and in
the revised National Adult Reading Test (NART-R)
(Nelson, 1991) for those patients and controls whose
MRI data were included in the analyses. Both groups
were matched for age, sex and years of education buthuman Huntington’s disease: Multi-modal evidence from diffusion MRI
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Table 2. Demographics and general cognitive proﬁle of patients and controls
Mean (SD) Patients (n= 21) Controls (n= 11) t-statistic (p-value)
% female 48 50 –
Age 45.6 (12.7) 51.4 (14.4) t(30) = 0.96 (0.35)
Years of Education 13.33 (2.68) 15.0 (4.4) t(30) = 1.32 (0.195)
NART-IQ 103 (12.9) 118.9 (7.5) t(29)* = 3.7 (0.001)
MoCA 22.7 (5.6) 27.18 (1.7) t(30) = 2.6 (0.015)
Abbreviations: MoCA=Montreal Cognitive Assessment score out of 30; NART-IQ = verbal IQ estimate based on the National Adult Reading Test.
* One patient could not perform the NART.
J. Bourbon-Teles et al. / Neuroscience xxx (2017) xxx–xxx 7the patient group performed less well than the control
group in the MoCA and the NART.Group diﬀerences in WM microstructure
With PCA, three components were extracted that
explained 66% of the variability in the WM
microstructural data (Table 3). The ﬁrst component
loaded positively on AD of left and right ATR, PFC-
caudate ﬁbers, SMA-putamen ﬁbers, CST and the CC1,
positively on RD of left and right ATR and PFC-caudate
ﬁbers and CC1, CC2 and CC3 and negatively on FA of
CC1, CC2, CC3 and positively on FA of left SMA-
putamen ﬁbers. Since this component predominantly
loaded highly on AD and RD it will be summarized as
‘‘diﬀusivity” component. The second component loaded
highly on MMPF in all tracts but not on any DT-MRI
indices and will hence be referred to as ‘‘MMPF”
component. The third component loaded positively on
FA of left and right ATR, PFC-caudate ﬁbers, CC1 and
right SMA-putamen ﬁbers and negatively on RD of left
and right SMA-putamen and CST. This component will
be referred to as ‘‘FA” component.
Independent t-tests revealed a signiﬁcant group
diﬀerence for the MMPF component [t(30) = 2.6,
p = 0.015, d= 0.92] and a trend for the diﬀusivity
component [t(30) = 2.2, p = 0.033, d= 0.94] [after
outlier exclusion t(29) = 2.3, p= 0.028] but no
diﬀerence for the FA component [t(30) = 0.69, p= 0.5,
d= 0.25] (Fig. 2A).Group diﬀerences in gray matter volume
One principal component for the subcortical volumetric
data was extracted which explained 76% of the variation
in the data and loaded highly on volumes of the
caudate, putamen, pallidum and thalamus in both
hemispheres (‘‘BG volume” component). For the
complete dataset there was no diﬀerence between the
groups in this component [t(30) = 1.67, p= 0.104,
d= 0.56]. However, after the exclusion of one control
participant with an outlier BG volume component score,
HD patients showed signiﬁcantly reduced BG volume
compared to healthy controls [t(29) = 4.15, p< 0.001]
(Fig. 2B).Please cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgGroup diﬀerences in cognition
The following two components that explained 76% of the
variation in the cognitive data were extracted: the ﬁrst
component loaded on all executive function tasks i.e.
performance in the Stroop, DSST, verbal trails, verbal
and category ﬂuency and box crossing performance
under single and dual task condition and will therefore
be described as ‘‘executive function” component. The
second component loaded on performance scores in the
digit span tasks only and will hence be labeled ‘‘verbal
span” component. Patients diﬀered from the controls in
the executive function component [t(31) = 4.3,
p  0.001, d= 1.7] but not in the verbal span
component [t(31) = 0.33, p= 75, d= 0.1] (Fig. 2c).
Spearman’s rho correlations between WM
microstructural components, BG volume component,
cognitive components and clinical UHDRS measures
There were signiﬁcant correlations between the patients’
inter-individual variation in the diﬀusivity component and
their performance in the two clinical measures of the
UHDRS. A positive correlation was found with
performance variation in the TMS (r= 0.74, p< 0.001,
n= 21) (Fig. 3A) and a negative correlation with
performance variation in the FAS (r= 0.69,
p< 0.001, n= 21) (Fig. 3B). These correlations
remained signiﬁcant after the exclusion of the patient
outlier that can be seen in Fig. 3 (TMS: r= 0.7,
p= 0.001, n= 20; FAS: r= 0.65, p= 0.002, n= 20)
but both were reduced when potential mediating eﬀects
of age, CAG repeats and YoE were partialled out (TMS:
r= 0.67, p= 0.01; FAS: r= 0.55, p= 0.05).
Patients’ inter-individual variation in FAS correlated
negatively with inter-individual diﬀerences in TMS
(r= 0.85, p< 0.001) (Fig. 3C). This correlation
survived partialling out of age, CAG repeats and YoE
(r= 0.91, p< 0.001) and the exclusion of one outlier
(r= 0.83, p< 0.001). In addition, patients’ inter-
individual diﬀerences in the executive component
correlated positively with FAS scores (r= 0.79,
p< 0.001, n= 21) (Fig. 3D) and negatively with TMS
scores (r= 0.78, p< 0.001, n= 21) (Fig. 3E). These
correlations remained signiﬁcant after partialling out of
age, CAG repeats and YoE (executive -TMS:
r= 0.80, p< 0.001; executive -FAS: r= 0.75,
p= 0.003).human Huntington’s disease: Multi-modal evidence from diffusion MRI
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Table 3. Rotated component matrix of the principal component analysis of the white matter microstructural data (N= 32)a
Tract-speciﬁc white matter
microstructural metrics
‘‘Diﬀusivity” component ‘‘MMPF” component ‘‘FA” component
Macromolecular Proton Fraction (MMPF)
ATR Left 0.18 0.77 0.03
Right 0.13 0.87 0.17
CC1 0.18 0.94 0.12
CC2 0.38 0.86 0.06
CC3 0.36 0.86 0.01
PFC-caudate Left 0.26 0.76 0.31
Right 0.06 0.83 0.10
SMA-putamen Left 0.01 0.75 0.15
Right 0.01 0.82 0.04
CST Left 0.01 0.91 0.07
Right 0.13 0.90 0.03
Axial Diﬀusivity (AD)
ATR Left 0.86 0.21 0.24
Right 0.87 0.13 0.26
CC1 0.72 0.15 0.37
CC2 0.44 0.19 0.10
CC3 0.16 0.30 0.24
PFC-caudate Left 0.73 0.13 0.28
Right 0.77 0.11 0.33
SMA-putamen Left 0.81 0.23 0.17
Right 0.76 0.21 0.16
CST Left 0.80 0.15 0.03
Right 0.71 0.42 0.11
Radial Diﬀusivity (RD)
ATR Left 0.79 0.09 0.49
Right 0.74 0.10 0.34
CC1 0.91 0.13 0.17
CC2 0.91 0.04 0.24
CC3 0.88 0.02 0.14
PFC-caudate Left 0.78 0.21 0.36
Right 0.61 0.39 0.44
SMA-putamen Left 0.01 0.10 0.69
Right 0.01 0.03 0.72
CST Left 0.06 0.10 0.52
Right 0.07 0.16 0.55
Fractional Anisotropy (FA)
ATR Left 0.07 0.14 0.86
Right 0.02 0.01 0.59
CC1 0.61 0.07 0.51
CC2 0.84 0.10 0.30
CC3 0.86 0.14 0.11
PFC-caudate Left 0.16 0.13 0.67
Right 0.11 0.26 0.77
SMA-putamen Left 0.53 0.16 0.49
Right 0.47 0.13 0.59
CST Left 0.41 0.06 0.35
Right 0.43 0.42 0.44
Loadings >0.5 are highlighted in bold. Abbreviations: ATR= Anterior Thalamic Radiation, CC= Corpus Callosum, CST = Cortico-spinal Tract, FA = Fractional Aniso-
tropy, MMPF =Macromolecular Proton Fraction, PFC= Prefrontal Cortex, SMA= Supplementary Motor Area, RD= Radial Diﬀusivity.
a Rotation method: Varimax with Kaiser normalization.
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negative correlation was present between inter-
individual diﬀerences in the diﬀusivity component and
the executive function component (r= 0.59,
p= 0.001, n= 30) (Fig. 3F) which remained signiﬁcant
after controlling for age and YoE (r= 0.62,Please cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgp= 0.023). Finally, inter-individual diﬀerences in the
diﬀusivity component also correlated negatively with the
BG volume component (r= 0.61, p< 0.001, n= 32)
(Fig. 3G). This correlation remained signiﬁcant after the
exclusion of two outliers (one patient, one control)
(r= 0.63, p< 0.001, n= 30) and after partialling outhuman Huntington’s disease: Multi-modal evidence from diffusion MRI
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Table 4. Component matrix of the principal component analysis of the
subcortical gray matter volumetric data (N= 32)a
Subcortical volume ‘‘BG volume” component
Caudate Left 0.844
Right 0.902
Putamen Left 0.923
Right 0.906
Pallidum Left 0.833
Right 0.868
Thalamus Left 0.844
Right 0.849
Loadings >0.5 are highlighted in bold.
Table 5. Rotated component matrix of the principal component
analysis of the cognitive data (N= 33)a
Cognitive Scores ‘‘Executive
function”
component
‘‘Verbal
Span”
component
Single digit span (attempted) 0.013 0.952
Single digit span (correct) 0.077 0.936
Dual task (attempted) 0.143 0.935
Dual task (correct) 0.193 0.922
Single box crossing 0.839 0.171
Dual box crossing 0.834 0.218
Stroop baseline RT 0.791 0.182
Stroop interference score 0.856 0.021
DSST 0.818 0.254
Verbal Trails baseline RT (sec) 0.557 0.285
Verbal trails switching RT (sec) 0.873 0.203
Verbal trails switching RT cost
(sec)
0.874 0.163
Verbal ﬂuency 0.852 0.049
Category ﬂuency 0.829 0.225
Loadings >0.5 are highlighted in bold. DSST = Digit Symbol Substitution Test,
RT = Reaction Time.
a Rotation method: Varimax with Kaiser normalization.
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correlations were signiﬁcant after multiple comparison
correction (see Table 6).
DISCUSSION
Based on i. evidence indicating that myelin breakdown
underpins WM damage in HD (Bartzokis et al., 2007;
Ernst et al., 2014; Huang et al., 2015; Teo et al., 2016)
and ii. histology evidence demonstrating that MMPF is
highly sensitive to the myelin content of WM (Schmierer
et al., 2007; Ou et al., 2009; Liu et al., 2015), the aim of
this study was to investigate whether MMPF was a sensi-
tive in vivo measure of WM degeneration in HD. Consis-
tent with this hypothesis we observed a signiﬁcant
reduction in a component that loaded highly on MMPF
in WM for HD patients relative to healthy controls
(Fig. 2A). The MMPF component loaded highly on all
reconstructed WM pathways (Table 3) suggesting that
myelin breakdown was present in all ﬁber bundles.
Although MMPF is sensitive to WM myelin, it is important
to recognize that this metric can also be inﬂuenced byPlease cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgchanges in glia cells and water content due to neuroin-
ﬂammation (Henkelman et al., 2001; Serres et al.,
2009a,b; Vavasour et al., 2011). In manifest HD it is likely
that inﬂammation goes hand in hand with myelin break-
down (Silajdzˇic´ et al., 2013; Rocha et al., 2016). However,
a recent CSF biomarker study found no evidence of neu-
roinﬂammation in premanifest HD (Vinther-Jensen et al.,
2016). It would therefore be informative to study diﬀer-
ences in MMPF in a cohort of premanifest gene-
expansion carriers. This might help with teasing apart dif-
ferent biophysical contributions to MMPF and would allow
to ﬁnd out if myelin breakdown constitutes an early fea-
ture of HD pathogenesis that may precede other neurode-
generative processes in HD (Bartzokis et al., 2007). The
MMPF component score of the one presymptomatic indi-
vidual (HD03) included in the present study was 0.567
which diﬀered more that three times the standard devia-
tion from the control mean component score
(M= 0.578, SD = 0.37). This observation suggests that
MMPF might already be reduced prior to disease onset
and that it would be worthwhile to investigate MMPF as
an early disease biomarker in a group of asymptomatic
gene carriers (Bartzokis et al., 2007). The novel contribu-
tion of the current study lies in the demonstration of
MMPF reductions in manifest HD and in highlighting the
potential of quantitative MRI markers in helping to better
understand HD pathogenesis.
This study also replicated a number of ﬁndings that
have previously been reported in the HD literature (e.g.
Gerard et al., 2015; Poudel et al., 2014; Odish et al.,
2015). Firstly, after the exclusion of one control outlier
we found evidence of BG volume loss in patients relative
to controls. BG atrophy is a well-established clinical fea-
ture of HD and striatal volume loss has been proposed
as biomarker for clinical trials (Aylward, 2014). We also
observed a trend for increases in the diﬀusivity compo-
nent with positive loadings on AD and RD. This group
comparison did not survive multiple-comparison correc-
tion but was of a comparable eﬀect size (d= 0.94) as
the MMPF eﬀect (d= 0.92). Increases in AD and RD
may arise due to multiple pathological changes likely to
co-occur in manifest HD including demyelination, inﬂam-
mation, axonal loss due to Wallerian degeneration and tis-
sue atrophy, all of which will contribute to the
manifestation of clinical symptoms. Indeed, we found
strong correlations between patients’ inter-individual vari-
ations in the diﬀusivity component and variation in the BG
volume component as well as performance variation in
the UHDRS-TMS and FAS and the executive functioning
component. These correlations were all in the expected
directions with positive associations between diﬀusivity
and TMS and negative associations with BG volume,
FAS and executive function (Fig. 3). However, the corre-
lations between the diﬀusivity component and the clinical
measures of disease stage (TMS and FAS) were partially
accounted for by patients’ diﬀerences in age, the number
of CAG repeat lengths and YoE suggesting that DT-MRI
diﬀusivities may be more general markers of disease
stage rather than indicating speciﬁc alterations in WM
microstructural properties. In contrast, FA was not sensi-
tive to HD related diﬀerences in WM (Odish et al., 2015).human Huntington’s disease: Multi-modal evidence from diffusion MRI
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Fig. 2. Group diﬀerences in white matter microstructure, basal ganglia volume and cognition. (A)
Mean component scores for patients with Huntington’s disease (patterned bars) and controls
(white bars) of the ‘‘diﬀusivity” component with positive loadings on axial and radial diﬀusivity, of
the component with positive loadings on the macromolecular proton fraction (‘‘MMPF compo-
nent”) and the component with positive loadings on fractional anisotropy (‘‘FA” component).
Patients showed signiﬁcantly reduced scores in the MMPF component, a trend for increased
scores in the diﬀusivity component but no diﬀerence in the FA component. (B) Mean component
scores of the ‘‘basal ganglia (BG) volume” component with positive loadings on volumes of the
caudate, putamen, pallidum and the thalamus on both hemispheres. After the exclusion of one
control participant’s outlier score HD patients showed signiﬁcantly reduced BG volume relative to
controls. (C) Mean component scores of the ‘executive function’ component with loadings on
performance in the Stroop task, Verbal and Category Fluency, Verbal Trails, Digit Symbol
Substitution task and box crossing under single and dual task conditions and the ‘‘verbal span”
component with loadings on performance in digit span only. Patients showed signiﬁcantly reduced
executive function performance but did not diﬀer in verbal working memory capacity from the
controls. Abbreviations: HD= Huntington’s Disease, FA = Fractional Anisotropy,
MMPF=Macromolecular Proton Fraction, SE = Standard error.
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remain constant and hence will not provide a sensitive
marker for disease-related changes in WM microstructurePlease cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in human Huntington’s dis
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.org/10.1016/j.neuroscience(Acosta-Cabronero and Nestor, 2014).
We propose that we did not ﬁnd any
correlations between clinical markers
and the MMPF component because
the latter may provide a more speciﬁc
metric of myelin impairment that on
its own may not be directly related to
disease stages.
With regard to the cognitive and
clinical measures we observed that
patients’ TMS and FAS ratings were
closely related with each other and
with the executive function
component, because patients at more
advanced stages of disease showed
poorer executive functioning.
Although we found that HD patients
relative to controls were signiﬁcantly
impaired in the executive functioning
component they did not diﬀer from
controls in their verbal working
memory span component. This
dissociation suggests that the well-
established impairments in multi-
tasking and executive functioning in
HD (Papoutsi et al., 2014; Mo¨rkl
et al., 2016; Stout et al., 2016) arise
due to deﬁcits in the control and
manipulation of information processing
rather than due to a reduced capacity
for storing verbal information in work-
ing memory (Baddeley, 1996). An
understanding of the nature of cogni-
tive deﬁcits associated with HD may
provide useful guidance for future
research into the eﬃcacy of cognitive
training and rehabilitation approaches
in HD (Andrews et al., 2015).
Our results were based on a
relatively small sample size of
patients and warrant replication in
larger samples sizes. Future
prospective longitudinal studies in
presymptomatic mutation gene
carriers far and close to disease
onset are required to assess the
utility of MMPF as a marker of early
disease development and
progression over time. In addition
there was also some variation in
patients’ medication and although we
are not aware of any documented
eﬀects of these drugs on the here
reported MRI indices we cannot
completely rule out that there might
have been any.
In summary, we provide novel
in vivo evidence for reductions in
MMPF, a proxy MRI marker of axonmyelin, in human Huntington’s disease. Expanding on
evidence from pathology and animal studies our resultsease: Multi-modal evidence from diffusion MRI
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Fig. 3. Spearman rho correlations between white matter microstructure, basal ganglia volume, cognition and clinical measures. (A) A positive
correlation between patients’ inter-individual variation in the diﬀusivity component scores and their Total Motor Score of the United Huntington’s
disease Rating Scale (UHDRS). Larger scores reﬂect more impaired performance or microstructure respectively. Please note that this correlation
remained signiﬁcant after the exclusion of one outlier that can be seen in the top right corner. (B) A negative correlation between patients’ inter-
individual variation in the diﬀusivity component and their Functional Assessment Score (FAS) of the UHDRS. Lower FAS scores reﬂect more severe
impairment. Please note that this correlation remained signiﬁcant after the exclusion of the outlier in the left bottom corner. (C) A negative correlation
between patients’ variation in the TMS and FAS which remained signiﬁcant after outlier exclusion. (D) A positive correlation between patients’ FAS
and their executive function component. (E) A negative correlation between patients TMS and their executive function component. (F) A negative
correlations between inter-individual variation in the diﬀusivity and executive function component across patients (black diamond) and controls
(white square). (G) A negative correlations between inter-individual variation in the diﬀusivity and basal ganglia volume component across patients
(black diamond) and controls (white square).
Table 6. Correlations between brain structural component, cognitive components and clinical markers
Spearman rho correlation coeﬃcient
(p-value)
‘‘Diﬀusivity”
component
‘‘MMPF”
component
‘‘FA”
component
‘‘Basal ganglia”
component
Total Motor Score 0.74 (<0.001) 0.32 (0.15) 0.03 (0.89) 0.52 (0.02)
Functional Assessment Score 0.69 (<0.001) 0.24 (0.28) 0.10 (0.66) 0.53 (0.01)
Executive function component 0.59 (0.001) 0.18 (0.35) 0.34 (0.06) 0.47 (0.01)
Verbal Span component 0.07 (0.71) 0.09 (0.64) 0.12 (0.54) 0.04 (0.84)
Correlations coeﬃcients that were signiﬁcant after Bonferroni correction are highlighted in bold. Trends deﬁned as correlations signiﬁcant at the uncorrected level are
highlighted in italics.
J. Bourbon-Teles et al. / Neuroscience xxx (2017) xxx–xxx 11suggest that myelin breakdown may contribute to WM
microstructural changes. Future studies in
presymptomatic mutation gene carriers are required to
clarify whether MMPF may provide an early biomarker
of myelin breakdown in HD.Please cite this article in press as: Bourbon-Teles J et al. Myelin breakdown in
and quantitative magnetization transfer. Neuroscience (2017), http://dx.doi.orgAcknowledgments—This research was funded by a Wellcome
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